Insider Trading1 Oct 2026, 01:43 pm
Skybiotech Healthcare Ltd: Trading Window Closure for Q2 FY27 Results
AI Summary
Skybiotech Healthcare Ltd has announced the closure of its trading window from October 1st, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter ended September 30th, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015. All designated persons and their immediate relatives are prohibited from trading in the company's securities during this period. The company will also inform the stock exchanges in due course about the board meeting date to consider and approve these financial results.
Key Highlights
- Trading window closed from October 1st, 2026.
- Closure is for Q2 FY27 unaudited financial results.
- Applies to designated persons and immediate relatives.
- Aims to prevent insider trading as per SEBI regulations.
- Board meeting date for results approval to be announced.
Price Impact
More from SKYBIOTECH